Cargando…
Flipping the script on macrophages in leiomyosarcoma
Macrophages promote the growth of leiomyosarcoma (LMS), a malignant soft-tissue tumor. CD47 on tumor cells binds to the macrophagic receptor signal regulatory protein α (SIRPα) and prevents phagocytosis. We showed that anti-CD47 monoclonal antibodies (mAbs) allow macrophages to engulf LMS cells and...
Autores principales: | Edris, Badreddin, Weiskopf, Kipp, Weissman, Irving L., van de Rijn, Matt |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494646/ https://www.ncbi.nlm.nih.gov/pubmed/23170280 http://dx.doi.org/10.4161/onci.20799 |
Ejemplares similares
-
Use of a KIT-specific monoclonal antibody to bypass imatinib resistance in gastrointestinal stromal tumors
por: Edris, Badreddin, et al.
Publicado: (2013) -
Improving macrophage responses to therapeutic antibodies by molecular engineering of SIRPα variants
por: Weiskopf, Kipp, et al.
Publicado: (2013) -
Comparative Gene Expression Profiling of Benign and Malignant Lesions Reveals Candidate Therapeutic Compounds for Leiomyosarcoma
por: Edris, Badreddin, et al.
Publicado: (2012) -
Macrophages are critical effectors of antibody therapies for cancer
por: Weiskopf, Kipp, et al.
Publicado: (2015) -
Macrophages: Good guys in colorectal cancer
por: Edin, Sofia, et al.
Publicado: (2013)